Skip to main content

Table 3 Chylomicron Retention Disease Follow-Up

From: Guidelines for the diagnosis and management of chylomicron retention disease based on a review of the literature and the experience of two centers

Early Follow-Up(Annual)

Clinical

Anthropometry

Weight and height to draw growth curve

Digestive

Appetite, diarrhea, abdominal distension, vomiting, hepatic size?

Neurological

Developmental retardation, areflexia, ataxia, dysarthria, deep proprioception loss, muscular weakness or pain, cramps?

Dietary counseling

Sufficient caloric intake, low fat diet (fat <30% total energy), EFA supplementation?

Biological

Lipids

Total and LDL cholesterol, HDL-C, TG

Hepatic

AST, ALT, GGT, total bilirubin, alkaline phosphatase?

Vitamins

Plasma levels of vitamins A, D, E and K or INR (vit K deficiency)

Essential Fatty Acids

Deficiency induced by low fat diet?

Blood cell count

Anemia?

Delayed Follow-Up(every 3 years)

 

1) After the age of 10 years

Hepatic

Ultranosonography (steatosis, portal hypertension, yearly), Elastometry Fibroscan®? (further studies are needed)

Neurological exam

Clinical, creatine kinase, electromyography

Ophthalmologic exam

Fundus, color vision, visual evoked potentials, electroretinography

Total body composition

Bone mineral content for whole body

2) Adult age

Echocardiography

Ejection fraction

  1. ALT, alanine aminotransferase; AST, aspartate aminotransferase; CK, creatine kinase; EFA, essential fatty acids; GGT, gamma-glutamyltranspeptidase; HDL, high-density lipoprotein; LDL, low-density lipoprotein; TG, triglycerides